Delivery Order SPE2DR25D2013-SPE2DR26F5QZY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $3,158.40 delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5mL syringes, with an ultimate completion date of January 9, 2026. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,202.77 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5ml syringes, with an ultimate completion date of December 5, 2025. This is a firm fixed price, non-set-aside contract performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,579.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of December 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that runs through December 2026 and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,168.19 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and older, 0.5ml syringes), with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child order under the company's...
- The Defense Logistics Agency (DLA) awarded a $2,632.00 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine syringes (12 years and up) on November 24, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,211.20 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5 milliliter syringes, with a firm fixed price and an ultimate completion date of February 6, 2026. This non-set-aside contract was competitively awarded on January 15, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccines (12 years and up) in 0.5ml syringes, with a completion date of January 2, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance based in Conshohocken, Pennsylvania and an ultimate completion date of December 26, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QZYDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,052.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5ml syringes, with a completion date of February 10, 2026. The contract was awarded on January 20, 2026, without a set-aside designation, indicating full and open competition. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical prime vendor contract (SPE2DX)—valued at up to $999,999,999.00 and running through December 2026, which enables comprehensive global pharmaceutical support for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's extensive federal contracting portfolio demonstrates proven capability to supply vaccines, prescription medications, and medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. This vaccine delivery order represents a routine task order execution under the company's established relationship with DLA Troop Support Medical, supporting immunization requirements for the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/19/26 |